Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$7,938,235
+$957,025 QoQ
Shares Held
31,546
-1.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#1,035
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Smithfield Trust Co holds $61,006,231 across 17 Drug Manufacturers - General names. ABBV ranks #4 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
79,661 | $20,231,503 | |
| 2 | MRK |
Merck & Co., Inc.
|
92,939 | $11,942,661 | |
| 3 | LLY |
ELI LILLY & Co
|
9,506 | $11,401,781 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
31,546 | $7,938,235 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
77,766 | $4,480,876 | |
| 6 | AMGN |
Amgen Inc
|
6,994 | $2,532,667 | |
| 7 | PFE |
Pfizer Inc
|
66,244 | $1,595,154 | |
| 8 | AZN |
Astrazeneca PLC
|
2,117 | $401,425 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,938,235 | 31,546 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $6,981,210 | 32,099 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $7,297,513 | 31,938 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $7,405,343 | 31,983 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $6,046,756 | 32,576 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $6,867,227 | 32,776 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $5,873,695 | 33,054 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $6,512,100 | 32,976 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,669,764 | 33,056 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $6,027,327 | 33,099 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $5,103,161 | 32,930 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $4,929,860 | 33,073 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $4,529,083 | 33,616 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $5,326,622 | 33,423 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $5,264,445 | 32,575 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,376,722 | 32,611 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,051,828 | 32,984 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,325,151 | 32,849 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,454,389 | 32,898 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,581,714 | 33,204 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,763,527 | 33,412 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $3,706,534 | 34,250 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,672,458 | 34,274 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,927,607 | 33,424 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,273,419 | 33,341 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,131,643 | 27,978 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||